17 August 2016 Near-infrared indocyanine dye permits real-time characterization of both venous and lymphatic circulation
Author Affiliations +
We investigated the optical properties of a near-infrared (NIR) fluorochrome, di-β-cyclodextrin-binding indocyanine derivative (TK-1), and its pharmacokinetic differences with indocyanine green (ICG). TK-1 was designed to have hydrophilic cyclodextrin molecules and, thus, for higher water solubility and smaller particle sizes than the plasma protein-bound ICG. We compared optical properties such as the absorption and fluorescence spectra, quantum yield, and photostability between both dyes in vitro. In addition, we subcutaneously injected a 1 mM solution of TK-1 or ICG into the hind footpad of rats and observed real-time NIR fluorescence intensities in their femoral veins and accompanying lymphatics at the exposed groin site to analyze the dye pharmacokinetics. These optical experiments demonstrated that TK-1 has high water solubility, a low self-aggregation tendency, and high optical and chemical stabilities. Our in vivo imaging showed that TK-1 was transported via peripheral venous flow and lymphatic flow, whereas ICG was drained only through lymphatics. The results of this study showed that lymphatic and venous transport can be differentially regulated and is most likely influenced primarily by particle size, and that TK-1 can enable real-time NIR fluorescence imaging of whole fluids and solute movement via both microvessels and lymphatics, which conventional ICG cannot achieve.
© 2016 Society of Photo-Optical Instrumentation Engineers (SPIE)
Toshikazu Kurahashi, Toshikazu Kurahashi, Katsuyuki Iwatsuki, Katsuyuki Iwatsuki, Tetsuro Onishi, Tetsuro Onishi, Tetsuya Arai, Tetsuya Arai, Katsunori Teranishi, Katsunori Teranishi, Hitoshi Hirata, Hitoshi Hirata, } "Near-infrared indocyanine dye permits real-time characterization of both venous and lymphatic circulation," Journal of Biomedical Optics 21(8), 086009 (17 August 2016). https://doi.org/10.1117/1.JBO.21.8.086009 . Submission:

Back to Top